spacer
The Healthcare Sales & Marketing Network celebrates 23 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  beta blocker 

 HSMN NewsFeed - 15 Mar 2017
FDA Approves Merck’s KEYTRUDA(R) (pembrolizumab) for Adult and Pediatric Patients with Classical Hodgkin Lymphoma (cHL) Refractory to Treatment, or Who Have Relapsed After Three or More Prior Lines of Therapy
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 24 Feb 2017
ANI Pharmaceuticals Acquires Inderal(R) XL and InnoPran XL(R)
Biopharmaceuticals Cardiology Acquisitions
 HSMN NewsFeed - 29 Aug 2016
Elite Announces Development and License Agreement with SunGen Pharma LLC
Biopharmaceuticals Generics Licensing
 HSMN NewsFeed - 6 Jun 2016
Allergan Announces FDA Approval of BYVALSON(TM) (nebivolol and valsartan)
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 16 Sep 2015
Amgen To Acquire Privately-Held Dezima Pharma
Biopharmaceuticals Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 6 May 2014
FDA Approves EPANOVA for the Treatment of Adults with Severe Hypertriglyceridemia
Biopharmaceuticals FDA
 HSMN NewsFeed - 13 Feb 2012
Medtronic Launches Two New Clinical Programs to Evaluate the Use of Symplicity(TM) 1 Renal Denervation System across Multiple Conditions
Devices Cardiology
 HSMN NewsFeed - 25 Oct 2010
Omeros Receives $20 Million from Vulcan Capital and $5 Million Grant Award from Washington State's Life Sciences Discovery Fund to Advance its GPCR Program
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 27 Sep 2010
DecImmune Therapeutics Secures $3.2 Million in Development Funding
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 25 May 2010
St. Jude Medical Enrolls First Patient in FAME II Clinical Trial to Study Use of Fractional Flow Reserve Technology in Patients With Stable Coronary Artery Disease
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Feb 2010
Forest Laboratories Receives Decision from FDA for Supplemental New Drug Application for Bystolic(R)
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 30 Dec 2009
QLT Acquires Early-Stage Ophthalmic Asset for US$7.5 Million
Biopharmaceuticals Ophthalmology Acquisitions
 HSMN NewsFeed - 23 Nov 2009
ARCA Receives FDA Fast Track Designation for Gencaro(TM) Development in Genotype-Defined Heart Failure Population
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 12 May 2009
Medtronic to Seek Indication Expansion for Heart Failure Device Therapy
Devices Cardiology FDA
 HSMN NewsFeed - 13 Apr 2009
BIOTRONIK, Inc. Announces The First U.S. Implant Of Lumax 540 Series - A Therapy For Patients Suffering From Heart Failure
Devices Cardiology
 HSMN NewsFeed - 11 Mar 2009
St. Jude Medical Announces European CE Mark Approval of Neurostimulation System for Chronic Angina
Devices Neurology Cardiology Regulatory
 HSMN NewsFeed - 24 Feb 2009
Heptares Secures GBP21 Million in Series A Fund Raising to Accelerate Development of Pipeline of Small Molecules Against High-Value GPCR Drug Targets
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 6 Nov 2008
FDA Approves Ranexa(R) for First Line Anti Anginal Use and Adds New Claims for Reduction of Ventricular Arrhythmias, Bradycardia, New Atrial Fibrillation and HbA1c
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 23 Oct 2008
NitroMed Announces Agreement to Sell BiDil(R) Drug Business to JHP Pharmaceuticals, LLC
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 24 Sep 2008
New Data Demonstrates Value of Cardiac Devices and Diagnostics in Managing Heart Failure Patients
Devices Cardiology
 HSMN NewsFeed - 1 Apr 2008
Lipitor Provided an Unexpectedly Potent Heart Benefit in Patients with Chronic Stable Angina, According to New Study
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 27 Feb 2008
Mylan Announces Amendment to Bystolic(TM) (Nebivolol) Agreement
Biopharmaceuticals
 HSMN NewsFeed - 27 Feb 2008
Forest Laboratories, Inc. Announces Amendment to Bystolic(TM) (nebivolol) Agreement
Biopharmaceuticals
 HSMN NewsFeed - 15 Jan 2008
NitroMed Reports on BiDil XR(TM) Progress Following FDA Meeting, Announces Restructuring and Suspension of BiDil(R) Sales Force, and Retains Investment Bank to Advise on Strategic Options
Biopharmaceuticals
 HSMN NewsFeed - 18 Dec 2007
Bystolic(TM), a Novel Beta Blocker, is Now Approved by the FDA for the Treatment of Hypertension
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 2 Dec 2007
FDA Issues Approvable Letter for Nebivolol for the Treatment of Hypertension
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 Nov 2007
Siemens Expands the SOMATOM Definition(TM) Line With World's First Adaptive CT Scanner
Devices Radiology
 HSMN NewsFeed - 6 Nov 2007
CV Therapeutics' Anti-Ischemic Agent Ranexa(R) Significantly Reduces HbA1c and Other Markers of Diabetes in MERLIN TIMI-36
Biopharmaceuticals Cardiology Endocrinology
 HSMN NewsFeed - 5 Nov 2007
Ranexa(R) Significantly Reduces Incidence of CV Death, MI or Recurrent Ischemia in MERLIN TIMI-36 Patients With Elevated BNP
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 6 Sep 2007
Ranbaxy Gains Approval to Manufacture and Market Carvedilol Tablets in the U.S. Market
Biopharmaceuticals Cardiology Generics FDA
 HSMN NewsFeed - 4 Sep 2007
Nebivolol Lowers Blood Pressure in Mild-to-Moderate Hypertensive Patients as Demonstrated in a Study Published in the Journal of Clinical Hypertension
Biopharmaceuticals
 HSMN NewsFeed - 16 Jul 2007
CV Therapeutics Names Lewis Stuart Senior Vice President, Commercial Operations
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 24 Apr 2007
Journal of the American Medical Association Publishes MERLIN TIMI-36 Results
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 22 Mar 2007
GSK Announces Nationwide Availability of Once-A-Day COREG CR(TM) for the Treatment of Three Key Cardiovascular Conditions
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 6 Mar 2007
Michael L. Sabolinski, M.D. Resigns from NitroMed
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Jan 2007
Kenneth M. Bate Named CEO of NitroMed
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Jan 2007
Bristol-Myers Squibb and AstraZeneca Announce Worldwide Collaboration to Develop and Commercialize Diabetes Compounds
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 28 Nov 2006
Siemens Introduces First Web-Enabled CT; SOMATOM Definition CT Receives FDA Approval for First Six Dual Energy Applications
Devices Radiology FDA
 HSMN NewsFeed - 31 Oct 2006
New Guidelines to Treat Behavior Problems Following Traumatic Brain Injury Published in Journal of Neurotrauma
Biopharmaceuticals Neurology Neurosurgery
 HSMN NewsFeed - 25 Oct 2006
Vasogen's ACCLAIM Trial of Celacade(TM) in Heart Failure Presented at the Canadian Cardiovascular Congress
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 20 Oct 2006
FDA Approves New, Once-a-Day COREG CR(TM) for the Treatment of Three Key Cardiovascular Conditions
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 11 Oct 2006
NitroMed Revises Sales and Marketing Strategy - Accelerates Development of Extended Release BiDil(R)
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 27 Sep 2006
MUSC Launches World's First Dual Source Heart CT Scanner
Devices Radiology Cardiology
 HSMN NewsFeed - 14 Sep 2006
ACTOS(R) (pioglitazone HCl) Demonstrates Significant Improvements in Cardiovascular Outcomes for High-Risk Patients With Type 2 Diabetes
Biopharmaceuticals Endocrinology Cardiology
 HSMN NewsFeed - 13 Sep 2006
Heart Failure Patient Quality of Care Improves at Hospitals in the Get With The Guidelines(SM) Program
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 13 Sep 2006
Vasogen's Celacade(TM) Shown to Significantly Reduce Time in Hospital in Prime Heart Failure Target Population
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 3 Sep 2006
New Data from Vasogen's ACCLAIM Trial in Heart Failure Presented at World Congress of Cardiology 2006
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 3 Sep 2006
New Analyses Show ACTOS(R) (pioglitazone HCl) Reduced Risk of Secondary Stroke by Almost 50 Percent in High-Risk Type 2 Diabetes Patients
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 27 Jun 2006
Two Leading U.S. Medical Centers Install Siemens SOMATOM Definition Computed Tomography System
Devices Radiology
 HSMN NewsFeed - 17 May 2006
New Data Show COREG CR (TM) Reduced Blood Pressure in Patients With Essential Hypertension
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 4 May 2006
FDA Confirms No Drugs are Therapeutically Equivalent to BiDil(R)
Biopharmaceuticals Cardiology Generics FDA
 HSMN NewsFeed - 21 Mar 2006
NitroMed Board Appoints New Senior Management
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Mar 2006
African American Heart Failure Trial Shows Women and Men Both Benefit from BiDil(R)
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 13 Mar 2006
Researchers Identify Gene Variations That May Determine Which Heart Failure Patients Are Likely to Benefit from Treatment With BiDil(R)
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 27 Jan 2006
FDA Approves Ranexa
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 20 Jan 2006
NitroMed Announces Optimization of BiDil(R) Contract Sales Force
Biopharmaceuticals
 HSMN NewsFeed - 17 Jan 2006
Gerald W. Bruce Joins NitroMed as Vice President, Sales
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Jan 2006
Mylan Laboratories and Forest Laboratories Announce Nebivolol Licensing Agreement
Biopharmaceuticals Licensing
 HSMN NewsFeed - 6 Jan 2006
NitroMed Promotes Michael Sabolinski, M.D. to the Position of Chief Medical Officer
Biopharmaceuticals Personnel
Return to NewsFeed  

 Additional items found! 37

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 37 additional stories matching:
beta blocker
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.